R. Y. Calne - Publications, H-index & Citations

R. Y. Calne

University of Cambridge

55H指数

359论文数

1.3W被引数

收录论文 7

发表时间

Life-threatening coagulopathy associated with use of Campath (Alemtuzumab) in maintenance steroid-free renal transplant given before surgery

AMERICAN JOURNAL OF TRANSPLANTATION

IF8.2

2008-04-01

PREAI

Ku, G.; Ting, W. C.; Lim, S. T. K.; Lee, B. T.; Calne, R. Y.

The influence of CYP3A gene polymorphisms on cyclosporine dose requirement in renal allograft recipients

KIDNEY INTERNATIONAL

IF12.6

2006-05-01

OAAI

Eng, H-S; Mohamed, Z.; Calne, R.; Lang, C. C.; Mohd, M. A.; Seet, W-T; Tan, S-Y

Adult small intestinal transplantation in England and Wales

BRITISH JOURNAL OF SURGERY

IF8.7

2003-03-20

OAAI

Middleton, SJ; Pollard, S; Friend, PJ; Watson, C; Calne, RY; Davies, M; Cameron, EAB; Gimson, AE; Bradley, JA; Shaffer, J; Jamieson, NV

Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days

TRANSPLANTATION

IF5

2000-10-01

137

OAAI

Ramirez, P; Chavez, R; Majado, M; Munitiz, V; Muñoz, A; Hernandez, Q; G-Palenciano, C; Pino-Chavez, G; Loba, M; Minguela, A; Yelamos, J; Gago, MR; Vizcaino, AS; Asensi, H; Cayuela, MG; Segura, B; Marin, F; Rubio, A; Fuente, T; Robles, R; Bueno, FS; Sansano, T; Acosta, F; Rodriguez, JM; Navarro, F; Cabezuelo, J; Cozzi, E; White, DJG; Calne, RY; Parrilla, P

Prope (almost) tolerance using campath in induction and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients, a follow-up of 7 to 21 months

TRANSPLANTATION

IF5

1999-05-01